Cargando…
Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine
Many current clinical therapies for chronic diseases involve administration of drugs using dosage and bioavailability parameters estimated for a generalized population. This standard approach carries the risk of under dosing, which may result in ineffective treatment, or overdosing, which may cause...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548536/ https://www.ncbi.nlm.nih.gov/pubmed/36225597 http://dx.doi.org/10.3389/fbioe.2022.986210 |